This week, 12 Health Care Equipment & Supplies stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Cooper Companies, Inc. (COO) is seeing ratings go up from a C last week to a B this week. Cooper Companies, Inc. develops, manufactures, and markets healthcare products. For more information, get Portfolio Grader’s complete analysis of COO stock.
Becton, Dickinson and Company (BDX) gets a higher grade this week, advancing from a B last week to a A. Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture, and sale of medical devices, instrument systems, and reagents. The company also gets A’s in earnings growth, earnings momentum, and return on equity. For more information, get Portfolio Grader’s complete analysis of BDX stock.
This week, Nevro Corp.’s (NVRO) ratings are up from a B last week to a A. The company also gets A’s in sales growth, earnings revisions, earnings surprise, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of NVRO stock.
ResMed Inc. (RMD) improves from a B to a A rating this week. ResMed Inc. develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing and other respiratory disorders. The company also gets A’s in return on equity. For more information, get Portfolio Grader’s complete analysis of RMD stock.
Hill-Rom Holdings, Inc.’s (HRC) ratings are looking better this week, moving up to a B from last week’s C. Hill-Rom Holdings, Inc. manufactures equipment for the healthcare industry, and provides wound care and pulmonary/trauma management services. The company also gets A’s in sales growth, earnings growth, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of HRC stock.
Cynosure, Inc. Class A (CYNO) earns a A this week, jumping up from last week’s grade of B. Cynosure, Inc. Class A develops, manufactures, and markets aesthetic treatment systems to the dermatology, plastic surgery, and general medical markets. The company also gets A’s in sales growth, earnings surprise, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of CYNO stock.
Baxter International Inc. (BAX) shows solid improvement this week. The company’s rating rises from a B to a A. Baxter International Inc. develops, manufactures and markets products related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company also gets A’s in operating margin growth, earnings growth, earnings momentum, and free cash flow. For more information, get Portfolio Grader’s complete analysis of BAX stock.
This week, Span-America Medical Systems, Inc. (SPAN) pushes up from a C to a B rating. Span-America Medical Systems, Inc. manufactures and distributes a variety of therapeutic support surfaces and related products made from polyurethane and other foam products for the medical, consumer and industrial markets. The company also gets A’s in free cash flow. For more information, get Portfolio Grader’s complete analysis of SPAN stock.
STAAR Surgical Company (STAA) boosts its rating from a C to a B this week. STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of STAA stock.
The rating of Volitionrx Limited (VNRX) moves up this week, rising from a C to a B. For more information, get Portfolio Grader’s complete analysis of VNRX stock.
This is a strong week for Akers Biosciences, Inc. (AKER). The company’s rating climbs to B from the previous week’s C. The company also gets A’s in sales growth. For more information, get Portfolio Grader’s complete analysis of AKER stock.
BIOLASE, Inc.’s (BIOL) ratings are looking better this week, moving up to a B from last week’s C. BIOLASE, Inc. develops, manufactures, and markets lasers systems for dental and medical applications and procedures in the United States and internationally. For more information, get Portfolio Grader’s complete analysis of BIOL stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
